In vitro human lymphocyte proliferative responses to a glycoprotein of the yeast Saccharomyces cerevisiae.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Immunology

• Publication date

  1994-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8157273PMCID PMC1422302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cord blood lymphocyte responses to food antigens for the prediction of allergic disorders.

  1992cited by this paper
• High frequency of cord blood lymphocytes against mycobacterial 65‐kDa heat‐shock protein

  1992cited by this paper
• Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes.

  1992cited by this paper
• Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae.

  1991cited by this paper
• The role of activated T lymphocytes in gastrointestinal disease

  1990cited by this paper
• Preliminary investigation on humoral and cellular immune responses to selected food proteins in patients with Crohn's disease.

  1990cited by this paper
• Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease?

  1990cited by this paper
• Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.

  1990cited by this paper
• Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans.

  1990cited by this paper
• Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin 2-activated killer cells.

  1989cited by this paper
• Candida albicans: Mannan and Protein Activation of Cells from Various Human Lymphoid Organs

  1989cited by this paper
• Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions.

  1988cited by this paper
• Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.

  1988cited by this paper
• Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions.

  1986cited by this paper
• Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response.

  1980cited by this paper

• Effect of live yeast Saccharomyces cerevisiae supplementation on immune factors in Japanese Black calves during the growth periods

  2023cites this paper
• Yeast-based vaccines: New perspective in vaccine development and application.

  2019cites this paper
• Beta-glucan-depleted, glycopeptide-rich extracts from Brewer's and Baker's yeast (Saccharomyces cerevisiae) lower interferon-gamma production by stimulated human blood cells in vitro.

  2016cites this paper
• Brewer's Yeast Supplementation Enhances Immune Response of Aged Mice.

  2015cites this paper
• Evaluation of the efficacy of yeast extract in reducing intestinal Clostridium perfringens levels in broiler chickens.

  2010cites this paper
• A dose-response evaluation of spray-dried yeast cell wall supplementation of diets fed to adult dogs: effects on nutrient digestibility, immune indices, and fecal microbial populations.

  2007cites this paper
• IgG and IgE immune response against the surface glycoprotein gp200 of Saccharomyces cerevisiae in patients with atopic dermatitis

  2004cites this paper
• Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease

  2004cites this paper
• Recent advances in the diagnosis and classification of inflammatory bowel disease

  2003cites this paper
• New diagnostic approaches in inflammatory bowel disease

  2003cites this paper
• 20 New diagnostic approaclies in inflammatory bowei disease

  2003cites this paper
• Diagnosis of inflammatory bowel disease: an update

  2000cites this paper
• 8 Diagnosis of inflammatory bowel disease: an update

  2000cites this paper
• Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

  2000cites this paper
• Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.

  1999cites this paper
• Immunological Effects of Biotherapeutic Agents

  1999cites this paper
• Characterization of oligosaccharides from an antigenic mannan of Saccharomyces cerevisiae

  1998cites this paper
• Further characterization of a high molecular weight glycoprotein antigen from the yeast Saccharomyces cerevisiae

  1996cites this paper
• Enhanced activation of human T cell clones specific for virus‐like particles expressing the HIV V3 loop in the presence of HIV V3 loop‐specific polyclonal antibodies

  1994cites this paper
• A murine monoclonal antibody directed against a yeast cell wall glycoprotein antigen of the yeast genus Saccharomyces.

  1994cites this paper